Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neoleukin Therapeutics, Inc. | General Counsel, SVP Legal | Stock Option (Right to Buy) | 100K | Aug 2, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NLTX | Neoleukin Therapeutics, Inc. | Aug 2, 2022 | 1 | $0 | 4 | Aug 4, 2022 | General Counsel, SVP Legal |
NLTX | Neoleukin Therapeutics, Inc. | Mar 14, 2022 | 1 | $0 | 4 | Mar 15, 2022 | General Counsel, SVP Legal |
NLTX | Neoleukin Therapeutics, Inc. | Mar 14, 2022 | 0 | $0 | 3 | Mar 15, 2022 | General Counsel, SVP Legal |